Axitinib plasma pharmacokinetics and ethnic differences.

Axitinib plasma pharmacokinetics and ethnic differences.

Item
http://www.wikidata.org/entity/Q38348548
Targeting hypoxic response for cancer therapyAssessment of ethnic differences in sunitinib outcome between Caucasian and Asian patients with metastatic renal cell carcinoma: a meta-analysis.A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients.Axitinib: a review in advanced renal cell carcinoma.Axitinib in metastatic renal cell carcinoma: beyond the second-line setting.Distribution of CYP2C19 polymorphisms in Mongolian and Han nationals and the choice of specific antiplatelet drugs.Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.Individualized dosing with axitinib: rationale and practical guidance.Genetic and ethnic modulation of cardiovascular toxicity of vascular endothelial growth factor inhibitors.Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma.Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study
P2860

Axitinib plasma pharmacokinetics and ethnic differences.

Item
http://www.wikidata.org/entity/Q38348548
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Axitinib plasma pharmacokinetics and ethnic differences.
@en
type
label
Axitinib plasma pharmacokinetics and ethnic differences.
@en
prefLabel
Axitinib plasma pharmacokinetics and ethnic differences.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Axitinib plasma pharmacokinetics and ethnic differences.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698